Simultaneous Determination of Everolimus, Sirolimus, Tacrolimus, and Cyclosporine-A by Mass Spectrometry

Measurement of immunosuppressive drug concentrations cyclosporine A (CyA), tacrolimus (TAC), sirolimus (SIR), and everolimus (EVE) in blood is an important application of therapeutic drug monitoring. These immunosuppressive agents are used in combined regimens and nowadays the liquid chromatography...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation proceedings 2020-06, Vol.52 (5), p.1402-1408
Hauptverfasser: Dinéia Perez, Juliana, Sanches Aragão, Danielle, Aparecida Ronchi, Fernanda, Febba, Andreia Cristina, Rosso, Claudia Felipe, Tedesco-Silva Junior, Hélio, Medina de Abreu Pestana, José Osmar, Casarini, Dulce Elena
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Measurement of immunosuppressive drug concentrations cyclosporine A (CyA), tacrolimus (TAC), sirolimus (SIR), and everolimus (EVE) in blood is an important application of therapeutic drug monitoring. These immunosuppressive agents are used in combined regimens and nowadays the liquid chromatography and tandem mass spectrometry is the best option for simultaneous analysis of these drugs in one short run. We developed an liquid chromatography and tandem mass spectrometry methodology in-house to measure the combination of immunosuppressants in a single blood sample from transplant patients in Brazil. We analyzed 235 combinations of 4 immunosuppressive drugs in patient blood to validate this study. The measuring ranges were 9 to 1000 ng/mL for CyA and 2 to 50 ng/mL for TAC, SIR, and EVE. Accuracy of the method was between 83.87% and 126.6% (coefficient of determination [r2] > 0.995). Validation of variation was ≤15% for lower limit of quantification. In our analysis 20% of patients treated with EVE showed concentration range of 6 to 6.9 ng/mL, 28% of patients treated with SIR showed a concentration range of 4 to 4.9 ng/mL to TAC, 22% of patients showed concentration range of 5 to 5.9 ng/mL, and finally 50% of patients treated with CyA showed concentration range of 20 to 30 ng/mL. Our routine laboratory was able to implement this new methodology in-house to measure simultaneous CyA, TAC, SIR, and EVE in a single blood sample from transplant patients with a sensibility and rapid quantification analysis. •Therapeutic drug monitoring is essential to measuring drugs concentrations in biological fluids.•Liquid chromatography–tandem mass spectrometry (LC-MS/MS) methods permit simultaneous measurement of 4 immunosuppressants.•LC-MS/MS analyzes a small volume of blood sample in 1-run analysis with faster analysis times and higher sensitivity and selectivity.•We developed an LC-MS/MS methodology in-house to measure any combination of immunosuppressants in a single blood sample from transplant patients all over Brazil.
ISSN:0041-1345
1873-2623
DOI:10.1016/j.transproceed.2020.01.077